Top Markets
Coin of the day
Quantum Genomics S.A. Quantum Genomics S.A.

Quantum Genomics S.A.

ALQGC
Rank in Stocks #37063
Quantum Genomics S.A., a biopharmaceutical firm established in Paris, France,... Quantum Genomics S.A., a biopharmaceutical firm established in Paris, France, in 2005, focuses on creating treatments for cardiovascular ailments. Its therapeutic approach utilizes the brain aminopeptidase A inhibition (BAPAI) platform, primarily addressing high blood pressure (hypertension) and heart failure. The company's key asset, firibastat, is currently undergoing a crucial Phase III study as a standalone therapy for hypertension and is also in clinical trials for heart failure. Additionally, Quantum Genomics is progressing QGC011 for hypertension in combination therapy, and further developing QGC006 and QGC606 to target both hypertension and heart failure.
Share Price
$0.07600875
Last synced: 2024-11-20
Market Cap
$2.06M
Change (1 day)
-0.51%
Change (1 year)
0.00%
Country
FR
Trade Quantum Genomics S.A. (ALQGC)

Category

EPS for Quantum Genomics S.A. (ALQGC)
EPS as of December 2024 TTM: $-0.26
According to Quantum Genomics S.A. latest financial reports and stock price the company's current EPS (TTM) is $-0.26. At the end of 2023 the company had a EPS of $-0.10 a decrease compared to its 2022 EPS that were of $-0.77.
EPS history for Quantum Genomics S.A. from 2009 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $-0.26 85.79%
2024 $-0.14 34.49%
2023 $-0.10 -86.97%
2022 $-0.77 6.11%
2021 $-0.73 -24.35%
2020 $-0.96 71.50%
2019 $-0.56 -35.77%
2018 $-0.87 -15.36%
2017 $-1.03 55.66%
2016 $-0.66 13.06%
2015 $-0.59 5.34%
2014 $-0.56 9.39%
2013 $-0.51 1.50%
2012 $-0.50 -89.65%
2011 $-4.84 -37.57%
2010 $-7.75 -10.46%
2009 $-8.66 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$17.32 -6,758.98%
US
$27.74 -10,765.13%
NL
- -
CH
- -
KR
$13.70 -5,367.24%
BE